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Summary.-Multicellular tumour spheroids (MTS) from 4 mouse tumours (Line 1
lung carcinoma; a fibrosarcoma, FSA; a mammary carcinoma, MCa-11; and
SV40-transformed fibroblasts, SV-A31) were injected into the abdominal cavity
of normal, immunized or tumour-bearing syngeneic mice, recovered after 4-48 h,
and their growth measured in vitro for 7-16 days. Both normal and immunized
mice inhibited MTS growth, but there was no correlation between the two types of
inhibition, suggesting that different immunological processes were involved. For
example, the greatest inhibition by normal mice was seen for the weakly immuno-
genic MCa-11, and the highly immunogenic tumour, SV-A31, was only moderately
inhibited. However, the summed inhibition of MTS growth in normal and sensitized
hosts corresponded to the behaviour oftumours as s.c. transplants; i.e., was inversely
related to the malignancy of the same tumours. The inhibition of MTS by mice bear-
ing identical early tumours (FSA or MCa-11) was comparable to that in immunized
mice. Histological sections of SV-A31 MTS in normal or immunized hosts revealed
the infiltration of MTS by various types of host cells, mostly polymorphonuclears,
macrophages and lymphocytes.
ANALYSIS ofimmunological anti-tumour
reactions can be conducted either in vivo
or in vitro, each approach having its own
advantages and disadvantages. In vivo
studies are relevant to the complex inter-
actions which must occur with primary
tumours, but precise quantitation and
isolation of variables is lost. In vitro
studies, on the other hand, provide precise
quantitation, but it is difficult to relate
the resultant data to the in vivo situation,
owing to the large differences in the nature
of the target-effector contact. Ideally, a
system for studying anti-tumour reactions
would include a simulation of the in vivo
target-effector interaction, followed by a
precise in vitro analysis.
A potentially useful target for such a
method, multicellular tumour spheroids,
or MTS, has existed for a number ofyears.
These MTS are growing aggregates of
tumour cells, which may be stable enough
to permit transfer to appropriate hosts
(into the abdominal cavity) followed by
harvest and in vitro analysis. Furthermore,
MTS represent target tumour tissue which
has many physical and physiological
characteristics in common with a solid
tumour in vivo. These include cell-to-cell
contacts (Sutherland & Durand, 1976),
presence of chronically hypoxic cell popu-
lations (Sutherland & Durand, 1976;
Yuhas et al., 1977; Yuhas & Li, 1978) and
cell-cycle times that range from exponen-
tial monolayer rates to essentially non-
dividing (Sutherland & Durand, 1976).
Since antigen expression is dependent on
cell-cycle stage (Fenyo et al., 1973), it is
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probable that its pattern in MTS would
be similar to that for tumours in vivo.
Furthermore, since live cells encompass
several layers in MTS (as in solid tumour
in vivo), the immunological effectors prob-
ably need to penetrate into the solid
tumour mass in order to exert the maxi-
mum anti-tumour effect. This further
implicates the question of how the local,
microenvironmental factor may influence
immunological reaction, which is largely
unknown. Many of these relations are
absent when the dissociated cells are con-
sidered as a tumour target.
In spite of the obvious advantages of
MTS as a target tumour tissue, it has not
been used in tumour immunology for a
long time. In a few recently reported
experiments, MTS was used for in vitro
(Sutherland et al., 1977) or in vivo (Mac-
Donald & Howell, 1978; MacDonald et al.,
1978) study of anti-tumour reaction in
alloimmune mice. Unfortunately, in these
and the other experiments, the method-
ology of producing of MTS was cumber-
some, and only 2 tumour lines, from
different species, were available in this
form (Sutherland et al., 1971, Sutherland
& Durand, 1976). Clearly, this would limit
the studies to the analysis of a single
tumour in a syngeneic host or 2 tumours in
different hosts. Indeed, in reported experi-
ments (Sutherland et al., 1977; MacDonald
& Howell, 1978; MacDonald et al., 1978)
the response ofallogeneic mice to only one
tumour was studied.
More recently, however, a simple
method for producing MTS has been de-
veloped in our laboratory, which has
allowed the study of more than 30 dif-
ferent tumours growing as MTS (Yuhas
et al., 1977, 1978; Yuhas & Li, 1978).
Furthermore, our method allows the
growth of MTS in stationary volumes of
liquid medium as small as 1 ml and,
contrary to those grown in spinner
bottles (Sutherland et al., 1971; Sutherland
& Durand, 1976), these MTS can be easily
handled and assayed for the growth in
vitro. Since it is now possible to study
and compare many tumours, we con-
sidered it worth while to pursue the poten-
tial of the system, and we present below
the results of our initial studies of 4 MTS
lines exposed to immune effectors in vivo
and assayed in vitro.
MATERIALS AND METHODS
Animals.-BALB/cJ and C3H/HeJ female
mice were obtained from the Jackson Labora-
tory (Bar Harbor, Maine). The animals were
maintained in standard laboratory conditions
and were used in experiments at age 3-5
months.
Tumours -Of the mouse tumours used,
3 are of BALB/c origin: a spontaneous
alveolar-cell carcinoma (Line 1), a radiation-
induced mammary carcinoma (MCa-11) and
BALB/c 3T3 fibroblasts (Clone A31) trans-
formed with SV40 virus (SV-A31). The 4th
tumour is a fibrosarcoma (FSA) induced by
methylcholanthrene in C3H mice. Further
details about the origin and history of these
tumours has been provided elsewhere (Yuhas
et al., 1977). All lines were grown in vitro in
EBME supplemented with 10% FCS, 50 u/ml
of penicillin and 50 jug/ml of streptomycin
(Gibco, Los Angeles, California). Cultures
wvere maintained at 37°C and 100% relative
humidity, with the gaseous phase consisting
of 50o CO2 in air. Details about growth rate
of these tumours in vitro as monolayers or
as MTS are presented elsewhere (Yuhas & Li,
1978).
The behaviour of these tumours in vivo
varies widely. Table I shows the pertinent
characteristics of each of the 4 tumours
studied. At one extreme is the highly malig-
nant, weakly immunogenic Line 1 lung car-
cinoma, and at the other the strongly immu-
nogenic, low-malignancy SV-A31 fibrosar-
coma.
Immnunization.-With all tumours immuni-
zation was performed in syngeneic mice,
and with Line 1 also in allogeneic mice.
Various sources of cells were used for immun-
ization: monolayers, spheroids and suspen-
sions obtained from in vivo tumours. Mice
immunized to FSA or MCa-11 were given 3
weekly injections of 1-2 x 107 X-irradiated
(10,000 rad) tumour cells. These mice were
able to reject 106 or more similar live tumour
cells. The same procedure was used for
immunization of syngeneic mice (BALB/c)
to Line 1, except 6 injections of X-irradiated
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cells were given, and challenge consisted of
104 cells. Only mice which rejected this dose
ofLine 1 cells (about 80%) within 25-30 days
of challenge were considered immune and
used in experiments. None ofthe normal mice
rejected the same dose of tumour cells. Allo-
geneic (C3H) mice were given 3-4 s.c. or i.p.
injections of 107 live Line 1 cells, the interval
between the first and second injection being
15-25 days, and 1 week between further
injections. For immunization to SV-A31
tumour 3 injections of 1-5 x 106 live cells
were given s.c. at 10-25-day intervals.
All mice, except BALB/c immunized to
Line 1 (see above), were used in experiments
15-25 days after the last immunization.
MTS production.-Between 105 and 106
tumour cells, harvested from monolayers,
were plated in 10 ml of complete media into
100mm Petri dishes, the bottoms of which
had been coated with 0.75% agar (Difco,
Kalamazoo, Michigan) in complete medium
(Yuhas et al., 1977). Within 1-2 weeks MTS
ranging in size from 200 to 400 ,um had de-
veloped. These MTS are not embedded or
attached to the agar-base, but are freely
moveable and readily selected and handled.
Injection and recovery of MTS.-Approxi-
mately 50 spheroids, measuring 250-300 jum
were injected aseptically in 0 5 ml of media
into the abdominal cavity ofthe mouse. Glass
0-25mlsyringes (Becton-Dickinson, Ruthford,
New Jersey), which do not retain MTS in the
neck, and metal 20-gauge needles were used
for injection. Four to 48 h later, mice were
killed, injected with 3 ml media and shaken.
Fifty units of heparin were added per ml of
washing medium. The abdominal cavity was
opened and the spheroids removed with a
Pasteur pipette, placed in a Petri dish, and
washed twice more in fresh medium. An
average of 15-30 MTS were recovered from
each mouse. Usually, fewer MTS were re-
covered from immunized than from normal
mice. A small percentage of MTS (mostly
SV-A31 MTS) lost their spheroid shape
during the incubation in vivo and appeared
either elongated (elliptic) or flat at the time
of recovery. The flat MTS were discarded,
and the rest ofMTS were selected at random
(without the use ofmicroscope) for the growth
assay. The elongated MTS were sized by
calculating the average of two perpendicular
diameters. The percentage ofMTS which lost
spherical shape was proportional to the
strength ofthe immune reaction and our data
therefore tend to underestimate the effect of
immunization.
Growth-inhibition as8ay.-Ten to 12 MTS
were placed individually in agar-based 16mm
(24-well) plates, along with 1 ml of medium.
The medium was changed twice weekly. They
were sized every second day for 7-16 days
with a dissecting microscope. The MTS of
tumours in these experiments differ consider-
ably in their growth rate (Yuhas & Li, 1978).
Therefore, for the sake of comparison,
growth-inhibition data for all tumours were
calculated when uninjected MTS (media
controls) grew to 400 ,tm; for Line 1 and
SV-A31 after 4-6 days (growth range 74-85
/tm and 75-87 ,m per day, respectively), for
FSA after 8-10 days (growth range40-51,um/
day) and for MCa-I1 after 14-16 days
(growth range 24-28,m/day). A certain per-
centage of Line 1, SV-A31 and FSA MTS
(mainly those recovered from immunized
mice) completely degenerated during the
observation period. Those MTS were not
included in growth curves, but their incidence
is shown separately. For slow-growing MCa-11
MTS, the observation period (15-16 days)
was sometimes too short to observe the com-
plete degeneration ofMTS. Withthat tumour,
the MTS which progressively decreased in
size and on Day 15 or 16 measured less than
half of the original size, were taken as
regressed and were excluded from growth
curves. Later experiments, in which the
growth of these MTS was followed longer,
showed that most of such MTS actually
regressed completely.
Colony-forming efficiency (CFE).-MTSre-
covered from groups of 2-3 mice were pooled
and sized. They were then divided in 2 groups
(10-12 MTS in each) of exactly similar sizes.
One group was dissociated and plated imme-
diately and the other after growth in vitro
for 3 days. Each group ofMTS was dissociated
by incubating them in 0 5 ml of 0.25%
Trypsin-EDTA (Gibco) and by occasional
aspiration with a lml syringe, using a 25-
gauge needle. Cells were counted in a haema-
cytometer, and 400 tumour cells were seeded
in 100 mm tissue-culture Petri dishes in 10 ml
complete media. The lymphoid cells infiltrat-
ing MTS were excluded from counts by their
difference in size and morphology. The num-
ber of lymphoid cells recovered from MTS
was probably too low to produce any sig-
nificant inhibition of colony growth after the
plating (the ratio to tumour cells was at most
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1:3). After 9 days of incubation (37° and
5% C02) the plates were washed, stained
with 0-75% crystal violet and colonies scored
macroscopically.
Cyclophosphamide (CY).-Cytoxan (Mead
Johnson, Evansville, Indiana) was dissolved
in water, and injected i.p. (250 mg/kg) within
1 h.
Histology.-MTS were processed for mor-
phological observation by methods which
have appeared earlier (Ladman & Yuhas,
1977; Yuhas et al., 1977; Ladman et al.,
1979). Sections of 3-6 MTS from identified
groups, cut 1-2 ,um in thickness, stained with
Toludine Blue 0 were examined by light
microscopy to identify the cells associated
with the MTS. In doubtful preparations,
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identification was checked in thin sections by
transmission electron microscopy.
RESULTS
Growth of MTS exposed to normal or
sensitized host
Fig. 1 shows the growth curves for 4
types ofMTS from the 4 tumour lines after
exposure for 24 h in the peritoneal cavity
of normal or immunized syngeneic hosts.
For FSA and MCa-11 tumours growth
curves are also included of MTS exposed
to mice bearing corresponding tumours.
MTS which, after the transfer in vitro,
regressed (see Materials and Methods) are
0 2 4 6 8 10 12 14
DAYS
FIG. 1. Growth in vitro ofMTS of 4 tumour lines exposed for 24 h in the peritoneal cavity ofnormal,
immunized, or tumour-bearing mice (mean + s.e. of MTS recovered from 2-4 mice per group).
Numbers on the curves indicate the fraction of MTS which regressed. A, medium controls;
0, normal mice; 0, immunized mice; *, tumour-bearing mice. Full lines, syngeneic mice;
dashes, allogeneic mice. Tumour-bearing mice were injected s.c. with 106 (FSA) or 3 x 106 (MCa-l )
cells 19 or 41 days respectively before the assay (tumour diameters 5-7 mm).
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excluded from the growth curves. Their
incidences are indicated separately in
Fig. 1.
As can be seen, the degree of inhibition
of the 4 tumours in both normal and
immunized mice differed considerably.
The growth pattern of Line 1 recovered
from normal syngeneic mice did not differ
from that of uninjected MTS (medium
controls). The effect of immunization in
syngeneic mice was very slight-there was
reduction in the growth of only 30-50 .tm
in comparison to normal mice. Exposure
of the same MTS to allogeneic immunized
mice showed that Line 1 is susceptible to
the immune attack (Fig. 1). The MTS
recovered from these mice decreased in
size initially and then resumed growth
after a delay of 5-6 days. The growth of
Line 1 recovered from normal allogeneic
mice was almost identical to that from
syngeneic counterparts, and is therefore
not shown.
With another tumour, SV-A31, the
effect of immunization in syngeneic mice
was much more pronounced. The growth
curve of MTS recovered from immunized
mice resembled that of Line l MTS
exposed to allogeneic immunized mice: an
initial decrease in size and the resumption
of growth after 4-5 days. The growth of
SV-A31 MTS recovered from normal mice
was also significantly inhibited. There
was a 1-2-day delay in growth of these
MTS in comparison with medium controls.
Essentially, similar effects to SV-A31
tumour were seen with FSA tumour, both
in normal and immunized mice. However,
the effect of immunization appears less
pronounced with FSA. With MCa-1 I
tumour, a very high degree of growth
inhibition was seen in normal mice. MTS
exposed to these mice slightly decreased
in size initially, and resumed growth after
5-6 days. The effect of immunization was
detectable, though not very pronounced.
It manifested in a slightly larger initial
drop in size and delayed resumption of
growth. Mice bearing early FSA and MCa-
11 tumours (diameter 5-7 mm) also in-
hibited significantly the growth of corres-
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FIG. 2. Influence of CY on MITS growth
inlibition by normal animals. A, medium
controls; 0, normal animals; 0, normal
animals given CY (250 mg/kg) 1 day before
MTS injection. Average growth of MTS
recovered from 2 animals per group.
ponding MTS. In comparison to immun-
ized mice, the inhibition by tumour-
bearing mice was somewhat weaker for
FSA, and stronger forMCa-1 1.
Inhibition of growth of SV-A31, FSA
and MCa-11. MTS by normal mice could
be due either to natural resistance of mice
to these tumours, or to experimental arte-
fact (i.e., caused by experimental manipu-
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FIG. 3. Inhibition of M1TS of 4 tumours by normal or immunized mice as a function of exposuro
time. Data for all tumours are taken when medium controls had increased in size to 400 ,um.
MTS recovered from 1-4 mice per point: 0, Line 1; x, MCa-11; A, SV-A31; ni, FSA. A, normal
mice compared to medium controls; B, immunized mice compared to normal mice; C, immunize(d
mice compared to medium controls. Full lines, syngeneic mice; dashes, allogeneic mice.
lation). To check this, MTS of these tu-
mours were injected either into normal
mice or mice given CY (250 mg/kg i.p.) 24
h before. Fig. 2 shows that CY pretreat-
ment almost completely abolished the
inhibition of FSA MTS, and to a sig-
nificant extent also that of MCa-11.
This effect was repeatedly observed with
MCa-11. Similar results were obtained
with SV-A31 (data not shown). Thus the
inhibition of MTS by normal mice is due
to natural resistance of animals to par-
ticular tumours.
Figure 3 shows the inhibition of growth
of 4 tumours by normal and immunized
mice as a function of exposure time. The
differences in size between MTS exposed
to normal mice and medium controls (Fig.
3A), and between those exposed to im-
mune and normal mice (Fig. 3B) are
shown. In Fig. 3C, the inhibition by
normal and immune mice is summarized.
Data for different tumours are compar-
able, since they were taken at equivalent
times after MTS transfer in vitro (see
Materials and Methods). Data on MTS
which regressed were not taken into
account; their inclusion, however, woulld
not change the overall picture.
The highest degree of inhibition by
normal mice was seen with MCa-11. The
inhibition of SV-A31 and FSA by normal
mice was half or less that ofMCa-11. With
both tumours it was proportional to the
exposure time and, with SV-A31, the
inhibition could be detected even after
4 h exposure. There was slight, if any,
inhibition of Line 1 in normal syngeneic
or allogeneic mice at any exposure time.
In immunized syngeneic mice the high-
est degree of inhibition, at all exposure
times, was found with SV-A31. Significant
inhibition of growth of this tumour could
be detected after 4 h exposure (more than
100 ,um). Inhibition of FSA MTS by
immunized mice was about half as strong
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as with SV-A31. A much smaller effect of
immunization was seen with MCa-11 and
Line 1. With the latter tumour, very slight
inhibition could be detected even after
exposure for 16 h or more.
All these tumours were also exposed to
normal and immunized host for 48 h (data
not shown). With MCa-l1 and FSA the
effect ofimmunization changed little from
24 h exposure, owing to the large increase
in inhibition by normal mice. SV-A31
MTS could not be recovered from immun-
ized mice they were already destroyed.
Inhibition of Line 1 MTS by immunized
mice increased proportionally, but was not
detectable in normal mice.
Inhibition of tumours by normal mice
(natural resistance) and induced immune
response probably both play a role in the
resistance ofhost to the tumour. The over-
all inhibition ofMTS growth in immunized
mice by comparison with medium controls
(Fig. 3C) is probably the sum of the inter-
action of both natural and induced im-
munity. The degree of inhibition of dif-
ferent tumours, as presented in Fig. 3C,
correspond fairly well to the behaviour of
the subcutaneous transplants of the same
tumours (Table I), being highest with the
least malignant tumour (SV-A31), lowest
with most malignant tumour (Line 1) and
intermediate with moderately malignant
tumours (FSA and MCa-I 1). The degree
of inhibition of SV-A31 in syngeneic mice
was comparable to that of Line 1 in allo-
geneic mice. Similar correlations to in vivo
malignancy of tumours could be found in
the incidence of the regression of MTS of
different tumours (Fig. 1). It was the high-
est with SV-A31 (more than 50%0 regres-
sions with 24h exposure) and the lowest
(nil) with Line 1.
Specificity of growth inhibition in
immunized mice
This was tested for SV-A31, Line 1 and
MCa-11 MTS in criss-cross pattern in
syngeneic (BALB/c) mice. A batch ofmice
was immunized to a particular tumour,
and all 3 types of MTS were given to the
mice from the same batch. At the same
time, MTS were given to the unimmunized
mice as a control. All MTS were recovered
after 24 h, except for Line 1, where, to
obtain a measurable inhibition, they were
recovered after 48 h. Table II shows the
net differences in size of MTS exposed to
immunized and normal mice. For different
tumours, values are taken at equivalent
times after the transfer (see Materials and
Methods). As can be seen, immunization
to Line 1 significantly inhibited MCa-11
and SV-A31 MTS, but to a lesser extent.
Immunization to SV-A31 or MCa- Il was
specific; only MTS of respective tumours
were significantly inhibited
In another experiment, the specificity
of growth inhibition of FSA MTS in C3H
mice was tested. Since MTS of other tu-
mours of C3H origin were not available,
cross-reactivity in C3H mice was tested
against allogeneic (Line 1) tumour. As
TABLE I.-Characteristics of 4 tumours used in the present study
Minimum S.c. growtl
cell dose for Immunio- Spontaneous rate
Tumouir Host Aetiology transplant* genicityt metastasist (mm/day)
Line 1 BALB/c Spontaneous 102 W!eak 100% Rapid
(0-56 + 0-07)
SV-A31 BALB/c Virus- 3-10 x 107 Strong None Very rapidl
in(luced detecte(d (1-1-3)
MCa-11 BALB/c Radiatioin- 1-5 x 106 Weak to Rare Slow
induced moderate (0-23 + 0 04)
FSA C3H Clhemically- 1-5 x 106 Moderate Ext,remely Rapid
in(tuced rare (0-56 +007)
* Minimum (lose ofmonolayer-derix-ed cells to prioduce 10000 takes of progressively growing tumours.
t Based on ability of clead tumour-cell immunization to increase tfhe live-cell dose for successful trans-
plantation.
t Frequency of spontaneous metastatic spread to the lungs from s.c. transplants.
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TABLE II. Specificity ofgrowth inhibition of MTS in BALB/c mice
Growth inhibition*
Mice Target MTSI
immunize(l
to Expt Line 1 MCa-1I SV-A31
Line I 1 - 99 + 13t -65 + 26t - 36 + 20
2 -136+41t - 29+35 - 51±+8t
AMean -117-5 - 47 - 43-5
MICa-l1
SAV-A31
1 - 12 + 35 - 130 + 30t
2 6+21 -100+36t
3 - 92+ 38t
4 - 106 + 29t
Mtean - :. -107
1 - 8+17 - 27+36
2 12+18 - 15+20
Mtean 2) - 21
- 17+28
- 8+16
- 12-5
-319±+ 35t
- 350±80t
-334.5
* The (lifferences in size (m + s.e.) between MITS expose(d to immunize(d andinormal mice (n C18; 1-2
per group). Negati- sign dtenotes slower growth in immunizedl grouip (inhibition). Tata are compare(i whlen
uninjected MTS of all 3 tumours grew to , 400 Hm.
t Significant at P < 0 05 (Student's t test).
I Line 1 MITS were expose(d to normal or immunize(l host for 48 h; MlCa- II an(l SV-A31 for 24 h.
TABLE III.-Specificity ofgrowth inhibition
of MTS in C3H mice
AMice
Immun-
ize(l to
Line I
FSA
Expt
1
:3
M\1ean
M\ean
Growtlh inlibition*
target MTSt
, ~~~A
Line 1 FSA
-413+351
- 72±+ 18
401 ±224 - 30 + 39
-423 + 151 - 92 + 21t
- 412 - 65
8 + 18
- 26+15
-9
- 176 + 16+
- 118+46+
- 147
* See footnotes to Table II.
t Exposed for 24 h to normal or immunizedl host.
I Significant at P < 0 05 (Student's t test).
Table III shows, immunization to a syn-
geneic tumour (FSA) had no influence on
the growth of an allogeneic tumour.
H-owever, immunization to Line 1 some-
times significantly inhibited also FSA
MTS, but far less than Line l.
Colony-forming efficiency of MTS exposed
to normal or immunized host
In order to see whether the growth
inhibition assay used in our experiments
correlated with other in vitro assays which
measure cell survival and reproduction,
the colony-forming efficiency (CFE) of
in vivo exposed MTS was investigated.
Line 1 and SV-A31 MTS exposed to syn-
geneic normal or immunized host were
dissociated and plated either imme-
diately after recovery (Day 0) or after
growth in vitro for 3 days. In Table IV, the
results are expressed as relative CFE
(number of colonies per 400 plated cells)
and as a number of clonogenic units (CU)
perMTS.
At Day 0, the CFE of Line 1 MTS re-
covered from normal mice was similar to
medium controls, and of those recovered
from immunized mice slightly reduced
(22%). The number of CU was slightly
reduced in normal group, and much more
so in immunized group (2.4 times less CU
than in medium controls). The greater
decrease in number of CU per MTS is due
to lower cell counts in MTS (of same size)
exposed to mice than in medium controls.
After 3 days' growth in vitro of Line 1
MTS, almost all differences between
groups disappeared. Still, there was a slight
reduction in the number of CU per MTS
in the immunized group, which correspond
to a slightly slower growth of the same
MTS.
In comparison to Line 1 MTS, at Day 0,
both the reduction of CFE and CU due to
107v
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TABLE IV.-Colony forming efficiency of MTS exposedfor 24 h to normal or immunized
mice
Time elapsed between recovery
of MTITS an(l assay (days)*
0
Colonies/ Colonies/
400 cells MTS
Tumour Host (%) (x 103)
C 79-2+5-1 136
(19.8)
Line I Normal 853+69 2-9 (21 3)
Immtinize(I 618 + 4-5 1-5
L Immunized (15-5)
71-2+ 1-8 2-1
(17-8)
SV-A.31 qNormal 617+18 1-5 SV-A:1l~~~~~ (15.4)
Jmmunize(l 28-2 + 2-2 0 53
L (7-1)
3
Colonies/ Colonies/
400 cells 1ITS
(°,) (x103)
717+22) 6-4
(17.9)
700+2-4 6-6
(17.5)
67-7 + 2-3 5-4
(16-9)
65-5+ 10
(16-4)
62-5 + 2-5
(15-6)
183+ 19
(4 6)
4 0
3-22
0.29
Growth
of MTS
(Gm)
238 + 15
235 + 5
194+ 9
248 + 20
202 + 28
-51 + 27
* MTS were reco-vered from groups of 2-3 mice, pooled, dissociated anid( plate(d either immediately (Day 0)
or after growth in vitro for 3 days. For each ttumour, exactly similar sizes of AITS were used in (lifferent
treatment groups and also on Day 0 and 3 within t,he same group (AITS diameter 418 + 11 3 ,um for SV-A31
and 394 + 6 3um for Line 1).
exposure in immunized mice were more
pronounced in SV-A31 MTS. Both ofthese
parameters were also significantly reduced
in SV-A31 MTS exposed in normal mice.
By allowing SV-A31 MTS to grow in
vitro for 3 days, the differences between
MTS exposed to normal mice and medium
controls diminished. On the contrary, in
immunized group all the differences from
medium control or normal mice enlarged.
Thus, in comparison to medium controls,
the number of CU in immunized group
was reduced - 4-fold at Day 0 and 18-fold
at Day 3. This parallels well the difference
in size of MTS in two groups after 3 days'
growth in vitro (299 am). It is interesting
that in the immunized group the CFE was
more reduced and the number of CU
smaller at Day 3 than at Day 0. This may
mean that delayed (3 days') dissociation
of MTS allowed prolonged (intimate) con-
tact ofimmune effectors and tumour cells,
whichinduced additional killing. However,
more data are needed to substantiate this.
Histological examninations
SVN-A31 MTS implanted into normal or
immune syngeneic mice were examined
histologically. Both MTS exposedl to the
normal and immunized mice were infil-
trated by many polymorphonuclear
neutrophilic leucocytes, fewer lympho-
cytes and occasional macrophages. The
extent of infiltration by leucocytes in
normal animals was similar to that in
immune animals. This was confirmed by
haemacytometer counts, in which about
one third of the cells conformed to leuco-
cyte size and morphology in both normal
and immunized mice. The degree of in-
filtration varied between individual MTS,
being much greater in those that had lost
their spheroid shape, suggesting that the
initial stages of degeneration may have
begun. The presence of cells within the
MTS, with the morphology ofpolymorpho-
nuclear neutrophilic leucocytes, lympho-
cytes and macrophages, was confirmed by
electron microscopy.
DISCUSSION
Although MTS, as any in vitro growing
tumour tissue, lack some characteristics
of tumours in vivo (e.g. they are not vas-
cularized), they do have many properties
(morphological, metabolic and kinetic
-which closelv resemble those of solid
tumours (Sutherland & I)urand, 1976;
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Yuhas et al., 1977; Yuhas & Li, 1978). For
example, although they are not vascular-
ized, the proportion of oxygen-dependent
dividing cells to undividing cells in MTS
seems to be close to that in the in vivo
growing tumour (Yuhas, 1980). Therefore,
MTS may be well suited to the study of
immunity to solid tumours. Although it
has been shown that MTS are sensitive to
in vitro attack ofalloimmune cells (Suther-
land et al., 1977), MTS offer a unique
possibility of a combined in vivo/in vitro
study of tumour immunity. Therefore,
in our present experiments we tried to
devise an assay in which tumour targets
(MTS) are exposed to immunological
effectors in vivo, the effect of which is
followed in vitro. Such an assay combines
the advantages of both in vivo and in vitro
assays; i.e., exposure of tumour cells in
the most physiological environment (the
animal), followed by quantitative in vitro
analysis. This approach has also been
recently used by others (MacDonald &
Howell, 1978; MacDonald et al., 1978),
for study of the effector phase of immune
reaction to allogeneic tumours. In the
present study, immunity of syngeneic
immunized ortumour-bearing mice, aswell
as of allogeneic mice, was tested against
several murine tumours.
Various other parameters commonly
used in in vitro assays, such as colony-
forming efficiency (CFE) (Sutherland et al.,
1977; MacDonald & Howell, 1978; present
experiments) or isotope incorporation
(Culo & Yuhas, unpublished) can be easily
used in our system for the detection ofthe
action of immune effectors on MTS. XVe
are using the inhibition of growth of MTS
as a parameter of tumour immunity be-
cause of its simplicity, and the possibility
of following the effect on the same target
for a long time. Furthermore, the growth
ofMTS in vitro can be easily related to the
situation in vivo, progression or regression
of solid tumour mass being the observed
effect in both cases. Thus, in the present
experiments there is a good correlation
between the degree of growth inhibition
(Fig. 3) or incidence of MTS regression
(Table I) and the growth of the same
tumours in vivo. Also, it seems that the
growth pattern ofMTS parallels quite well
the other more commonly used parameters
for measuring cell survival and reproduc-
tion in vitro. This was demonstrated in the
experiment in which CFE and the growth
of MTS were measured. Both, the growth
inhibition and reduction of CFE in syn-
geneic mice were more pronounced with
highly immunogenic (SV-A31) than with
lowly immunogeneic (Line 1) tumour
(Table IV). The slight discrepancy be-
tween the two assays, appearing when
Line 1 MTS recovered from normal mice
and medium controls are compared (sig-
nificant reduction of CU/MTS and prac-
tically no inhibition of growth), might
indicate that CFE may be more sensitive
to damage of tumour cells than is the
growth assay. However, this may be only
an artefact.
For example, during incubation in a
syngeneic host, MTS might, for some
reason, swell and increase in size, without
a proportional increase in cell count.
Naturally, this will reduce the number of
clonogenic units relative to medium con-
trols of the same size. Supporting this are
the facts that relative CFE (number of
colonies per 400 cells) was notreduced, and
that the differences from medium controls
disappeared after 3 days' culture in vitro.
A highdegree oftumourimmunity could
be detected in the Line 1 system in allo-
immune mice. Other investigators showed
that plating efficiency of MTS exposed to
alloimmune mice is greatly reduced, 99%o
or more reduction of clonogeneic cells was
obtained with 48h exposure (MacDonald
& Howell, 1978). In our experiments we
were unable to recover the MTS (Line 1)
from alloimmune mice after 48 h they
were already destroyed. This may be
partly due to a lower MTS size used in our
experiments than in those mentioned
above (250-350 vs 700-900 pum). However,
almost 500o Line ] MTS regressed after
24 h exposure to alloimmune mice, in-
dicating that few if any tumour cells
survived.
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More interesting, however, was the
effect of immune response of syngeneic
animals on the growth of MTS. By using
4 tumour lines, it was shown that 3
tumours were inhibited to a high degree
by normal animals. Inhibition of some
MTS by normal animals might reflect the
natural killer activity, whichwasrepeated-
ly seen in mice both in vivo and in vitro
(reviewed by Herberman & Holden, 1978).
As in short-term 51Cr-release assay, com-
monly used for detection of natural killer
activity in vitro, inhibition ofMTS growth
(SV-A31) could be detected after a 4 h
exposure. On the other hand, exposure of
a resistant tumour line (Line 1) for 48 h
to normal animals produced no measur-
able anti-tumour effect. The inhibitory
effect of normal mice was significantly
reduced by their pre-treatment with CY,
an agent known to abolish natural killer
activity (Oehler & Herberman, 1978).
Furthermore, inhibition of SV-A31 MTS
was stronger in young than in old animals,
and in T-cell-deprived animals than in
normal (Culo & Yuhas, unpublished).
Although these observations are in agree-
ment with knownfacts about natural killer
activity (Herberman & Holden, 1978;
Shellam, 1977), further study is required
before definite conclusions can be reached
concerning the relationship ofour observa-
tions to classical naturalkillermechanisms.
The effect ofimmunization of syngeneic
animals to 4 tumours differed widely. It
was barely detectable with Line 1, and
highly pronounced with SV-A31. By
looking at either growth curves or inci-
dence oftumour regressions (Fig. 1) or the
quantitative degree of inhibition (Fig. 3)
striking similarities could be found be-
tween inhibition of SV7-A31 MTS by syn-
geneic immunized mice and Line 1 MTS in
allogeneic immunized mice.
The immunity of tumour-bearing ani-
nmals could also be detected by this assay.
The inhibition of MTS growth by mice
bearing early FSA or MCa-11 tumours,
when compared to corresponding immun-
ized mice, was either somewhat weaker
(FSA) or significantly stronger (MCa-1 1).
It appears, therefore, that the MTS
growth-inhibition assay might be well
suited to study of the concomitant im-
munity in vivo. The advantage of this
assay over other in vivo assays would be
the opportunity for variation of exposure
to tumour, use ofsmall numberofanimals,
etc.
There was no correlation between sus-
ceptibility oftumours to natural immunity
effectors and their immunogenicity. Thus
MCa-11 was very susceptible to natural
effectors and of rather low immuno-
genicity. Natural resistance to SV-A31was
moderate and immunogenicity very high,
etc. This is most probably related to
different effector cells being involved in
natural and induced immunity (Herber-
man & Holden, 1978) and, therefore, to
different recognition structures involved
in the two processes.
Both natural resistance and induced
immunity play varying roles in resistance
ofanimals to tumours in vivo. The correla-
tion ofthe growth inhibition ofMTS to the
growth or malignancy of tumours in vivo
was seen only if inhibition of MTS growth
in normal and immunized mice was
summed (Fig. 4C).
Inhibition of MTS growth in vivo seems
to be fairly specific in immunized syn-
geneic mice, at least for 3 out of 4 tumours
tested (SV-A31, MCa-11 and FSA). Im-
munization to Line 1 tumour induced
some inhibition of 2 other syngeneic
tumours. Similarly, allogeneic mice immu-
nized to Line 1 tumour also inhibited
somewhat the syngeneic (FSA) tumour,
whereas there was no cross-reactivity in
the opposite direction. Inhibition of syn-
geneic tumours by mice immunized to
allogeneic tissue has also been reported by
others (Kobayaslhi et al. 1974; Bear et al.,
1977), and is thought to be caused by
nonspecific immune mechanisms (Gotohda
et al., 1976). The undirectional cross-
reactivity might, for example, be due to
the boosting of natural killer activity by
one tumour but not by the other, and thus
cross-reactivity in the classical sense
(sharing ofantigens) mightnotbeinvolved.
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Regarding the mechanism of the in-
hibition ofMTS growth, it is probable that
it is mediated by cellular, not humoral
mediators, at least in the allogeneic situa-
tion. Thus we were unable to show any
growthinhibition ofLine 1 MTS implanted
in a diffusion chamber into alloimmune
mice, or exposed in vitro to the serum of
the same animals (unpublished). Using
the 51Cr-release assay, MacDonald et al
(1978) showed that in the alloimmune
system the cytotoxic cells within MTS are
nonadherent T cells. However, in another
model, in which the cytotoxicity of
immune cells infiltrating the in-vivo-
implanted sponges previously filled with
allogeneic cells was investigated, the non-
T allogeneic immune cells showed the
highest activity (Roberts & Hayry, 1976;
Hayry & Roberts, 1977). In both models,
the cells which infiltrated the graft were
more cytotoxic per cell than cells outside
the graft (i.e., in the peritoneal cavity,
spleen or lymph nodes). No significant
infiltration of allogeneic MTS by normal
host cells was seen (MacDonald et al.,
1978). In our experiments, however,
where a syngeneic model (SV-A31) was
used, the infiltration of cells from normal
mice was almost as extensive as from
immunized mice. Although the difference
may originate from the different models
used (allogeneic vs syngeneic), it is prob-
ably related to the fact that normal mice
exerted an anti-tumour activity in our
model, but not in model of MacDonald
et al. (1978).
Interestingly, all kinds of leucocytes
(polymorphonuclears, lymphocytes, mac-
rophages and plasma cells) and probably
even mast cells could be seen within syn-
geneic MTS. Similar data were obtained
when infiltration by host cells of in-vivo-
growing tumour was studied (Haskill
et al., 1975). The role of these subpopula-
tions of syngeneic lymphoid cells in MTS
growth inhibition is at present being
investigated in an in vitro assay.
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